Company intelligence / Profile preview
Melsmon Pharmaceutical
Osaka, Osaka Prefecture, Japanmelsmon.co.jp ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
Melsmon Pharmaceutical specializes in pharmaceutical-grade placenta extracts derived from human or animal sources. Its flagship product "Melsmon" has been used since the late '50s for menopause symptom relief and later expanded into cosmetic/anti-aging applications. Clinical studies have shown benefits in tissue oxygenation, regeneration, fatigue reduction, blood clotting improvement, and skin rejuvenation. The company also produces supplements using horse placenta extract combined with antioxidants like French pine bark extract. Products are certified in Japan, Korea, Russia/NIS.
- Therapeutic areas
- DermatologyWomen's HealthOther
- Modalities
- BiologicProteinHormoneSmall molecule
- Industry
- Biotech
02
Drug pipeline
4 assets3 more assets in the full pipeline.
Beyond the preview
Go deeper on Melsmon Pharmaceutical.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Melsmon Pharmaceutical.